| Tag | Content |
|---|
EnhancerAtlas ID | HS116-17024 |
Organism | Homo sapiens |
Tissue/cell | Left_ventricle |
Coordinate | chr19:16461960-16462760 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXH1 | MA0479.1 | chr19:16462583-16462594 | CCCAATCCACA | + | 6.14 | | POU2F2 | MA0507.1 | chr19:16462081-16462094 | ATATGCAAATAAG | - | 6.57 |
|
| | Number of super-enhancer constituents: 6 | ID | Coordinate | Tissue/cell |
| SE_10209 | chr19:16462017-16462643 | CD19_Primary | | SE_17319 | chr19:16461750-16462812 | CD4p_CD25-_CD45RAp_Naive | | SE_38557 | chr19:16461771-16463125 | HUVEC | | SE_53383 | chr19:16461849-16462971 | Spleen | | SE_61491 | chr19:16432573-16510994 | Toledo | | SE_62295 | chr19:16434424-16512260 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH19I016351 | chr19 | 16462018 | 16462667 |
|
Enhancer Sequence | CAGGGGTTCA CTGCTTTCCC TAAAAACGTC CCCTCCCCTG GGTAAGAGCT CCTAATTCAA 60
TACATGGTTT TCCATTTCTA AGATATCAAG AGCCATCACC TGCCTCTTCT GGGTACGGTG 120
AATATGCAAA TAAGCAGAAG ACAACAAGAA ACTAGAAACC CTGAAGTTTT CTAAGAAACC 180
CTCAATTCTT TTCTCAAATC AGCAAAACGA GCCTCCGCCC CTGGCTGGCT TCGGAGCTCT 240
GGGCAAATGA CTGCAGGGAA TGAGTCTCAG TTTTCCCTCA GGAAAATGGG CTAACATCCA 300
CCCTCTTCAT TTACAAGGTT GCTTTGAGTT TCCAACAAGA TAATGGAAGC TGAATCGCTG 360
TGAAAATTGT GAAGTCCCAA ACCAAATGGT GCCAAAGCTG TGACTACCCT GGAGAGAGGT 420
GACTCAGCGC CTTCTCCAAA GGGATCTATC ACGGCAGAAG CACATGGCTT GGGACCTTCA 480
GATTCACTCT GGGGTTTTCC TGCAGGAGGA AGGAAGTATT GGGAATTGCC TCCGGCCATG 540
ACCACTTTCA GGAAGCTGCT CGTTTTTGCA GAGAAGATTA GGGGCATCTC AGAGGTTACA 600
AAGCCCACGA GGCCCCACCA GGCCCCAATC CACAAAGCAG GCCCATTCCA TGGGCACCAA 660
GAAGACGTCC CCTCCCAACA CCCTCATCTC CAGGACTGCA GGGACCCCTC GAGGGTCTGT 720
AACCTGGAAA AGGGGGATTA CCAAAGGTTT GGAATCTTTA CATTCGCCCA AATCCACCAT 780
AAACTTCAGT TTATGGTTTA 800
|
